Denali Therapeutics
The Director, Bioassay Development leads the Bioassay Development function within Technical Operations Analytical & Formulation Development, providing strategic leadership for potency and impurity assay development for complex protein biologics. This role involves mentoring a team, building functional capabilities, and partnering cross-functionally to ensure bioassay strategies support clinical development, regulatory submissions, and commercial readiness. The position requires deep technical expertise in biologics potency methods, method qualification, and GMP readiness to deliver innovative therapies for serious diseases.
Headquarters
South San Francisco, California, United States
Company Size
201-500 employees
Founded
2015
Denali Therapeutics brings the power of biotherapeutics to the whole body, including the brain. We discover, develop and deliver medicines for people living with serious diseases.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Denali Therapeutics.
15% above the average for this role
Scientist, Analytical Cell Line Engineering & Bioassay Development
BioLife Plasma Services
Associate Principal Scientist – Bioassay, Cell Based Sciences, AR&D
MSD
Senior Scientist I, Analytical Development, Biologics CMC
Exelixis
QC Bioassay Principal Scientist
Alvotech
Bioassay Scientist/Sr. Scientist, Analytical Development
Neurocrine Biosciences
Associate Scientist II, Analytical Development (Protein-Based Assays)
Forge Biologics